The Primary
Care Companionfor CNS Disorders

Neurodevelopmental

Article July 14, 2006

Introduction: New Developments in the Treatment of Attention-Deficit/Hyperactivity Disorder

Joseph Biederman, MD

J Clin Psychiatry 2006;67(suppl 8):3-6

Article Abstract

Download Free PDF

This PDF is free for all visitors!

Save

Cite

INFORMATION FROM INDUSTRY

AUVELITY is an FDA-approved treatment for adults with MDD. Auvelity, is a rapid-acting antidepressant with a multimodal mechanism, targeting both glutamatergic and monoaminergic pathways. Learn more about how AUVELITY is thought to work and side effects. Please see Important Safety Information within this document and the full Prescribing Information.

Vol 26 • 2024 • Number 6

Read the Current Issue

Narrative Review

Dextromethorphan-Quinidine for Agitation in Dementia

Original Research

Psychiatric Comorbidities in Adolescents With Polycystic Ovary Syndrome

Original Research

Intervention to Enhance Mental Health Competency

Original Research

Evolution of Treatment Modalities for PTSD

Rounds in the General Hospital

Etiology, Prevention, and Management of TD

Rounds in the General Hospital

Comorbid Bipolar Disorder and PTSD

View current Issue

Article

Stimulant Formulations for ADHD

December 27, 2018

Various formulations of methylphenidate and amphetamine are approved for the treatment of ADHD. The drug delivery mechanisms of these compounds create unique parameters that differ considerably among the formulations....

Mohan Gautam, Deepak Prabhakar

Article

Medications for ADHD

August 18, 2016

With more than 20 different pharmacologic options for the treatment of ADHD, how do you know what will work best for your patients? Read this systematic review to find...

Rakesh Jain, Alain Katic

Article

Nonmedical Stimulant Use in College Students

July 27, 2016

Misuse of stimulants among college students may be associated with a separate psychiatric disorder. Read this cross-sectional study to help identify which of your patients are more likely to...

Timothy Wilens, Courtney Zulauf, MaryKate Martelon, et al

Introduction: New Developments in the Treatment of Attention-Deficit/Hyperactivity Disorder

Read the Current Issue

Dextromethorphan-Quinidine for Agitation in Dementia

Psychiatric Comorbidities in Adolescents With Polycystic Ovary Syndrome

Intervention to Enhance Mental Health Competency

Evolution of Treatment Modalities for PTSD

Etiology, Prevention, and Management of TD

Comorbid Bipolar Disorder and PTSD

ELSEWHERE:

FOLLOW US:

Introduction: New Developments in the Treatment of Attention-Deficit/Hyperactivity Disorder

Read the Current Issue

Dextromethorphan-Quinidine for Agitation in Dementia

Psychiatric Comorbidities in Adolescents With Polycystic Ovary Syndrome

Intervention to Enhance Mental Health Competency

Evolution of Treatment Modalities for PTSD

Etiology, Prevention, and Management of TD

Comorbid Bipolar Disorder and PTSD

Related Articles

Stimulant Formulations for ADHD

Medications for ADHD

Nonmedical Stimulant Use in College Students

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles